NO326141B1 - Fremgangsmate for behandling av isolert systolisk hypertensjon - Google Patents
Fremgangsmate for behandling av isolert systolisk hypertensjon Download PDFInfo
- Publication number
- NO326141B1 NO326141B1 NO19995797A NO995797A NO326141B1 NO 326141 B1 NO326141 B1 NO 326141B1 NO 19995797 A NO19995797 A NO 19995797A NO 995797 A NO995797 A NO 995797A NO 326141 B1 NO326141 B1 NO 326141B1
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- procedure
- systolic hypertension
- isolated systolic
- isolated
- Prior art date
Links
- 206010042957 Systolic hypertension Diseases 0.000 title claims 3
- 239000002080 C09CA02 - Eprosartan Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- OROAFUQRIXKEMV-LDADJPATSA-N eprosartan Chemical compound C=1C=C(C(O)=O)C=CC=1CN1C(CCCC)=NC=C1\C=C(C(O)=O)/CC1=CC=CS1 OROAFUQRIXKEMV-LDADJPATSA-N 0.000 claims 2
- 229960004563 eprosartan Drugs 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Fixed Capacitors And Capacitor Manufacturing Machines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4780097P | 1997-05-27 | 1997-05-27 | |
PCT/US1998/010794 WO1998053816A1 (en) | 1997-05-27 | 1998-05-27 | Method of treating isolated systolic hypertension |
Publications (3)
Publication Number | Publication Date |
---|---|
NO995797L NO995797L (no) | 1999-11-26 |
NO995797D0 NO995797D0 (no) | 1999-11-26 |
NO326141B1 true NO326141B1 (no) | 2008-10-06 |
Family
ID=21951046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19995797A NO326141B1 (no) | 1997-05-27 | 1999-11-26 | Fremgangsmate for behandling av isolert systolisk hypertensjon |
Country Status (24)
Country | Link |
---|---|
US (1) | US20020040045A1 (es) |
EP (1) | EP1003506B1 (es) |
JP (1) | JP2002500673A (es) |
KR (1) | KR20010013014A (es) |
CN (1) | CN1257427A (es) |
AR (1) | AR012872A1 (es) |
AT (1) | ATE307580T1 (es) |
AU (1) | AU740646B2 (es) |
BR (1) | BR9809611A (es) |
CA (1) | CA2288722C (es) |
CZ (1) | CZ298390B6 (es) |
DE (1) | DE69832075T2 (es) |
ES (1) | ES2251083T3 (es) |
HU (1) | HUP0003249A3 (es) |
IL (1) | IL132154A (es) |
MX (1) | MXPA99010970A (es) |
NO (1) | NO326141B1 (es) |
NZ (1) | NZ337888A (es) |
PL (1) | PL191971B1 (es) |
SA (1) | SA98190174B1 (es) |
TR (1) | TR199902914T2 (es) |
TW (1) | TW579296B (es) |
WO (1) | WO1998053816A1 (es) |
ZA (1) | ZA984421B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060160871A1 (en) * | 2004-12-07 | 2006-07-20 | Nektar Therapeutics | Stable non-crystalline formulation comprising losartan |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US544080A (en) * | 1895-08-06 | Centrifugal filtering-machine | ||
US5418250A (en) * | 1989-06-14 | 1995-05-23 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
US5185351A (en) * | 1989-06-14 | 1993-02-09 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists |
JPH05199342A (ja) * | 1991-05-20 | 1993-08-06 | Xerox Corp | 無声の手書きによる携帯式通信装置および方法 |
-
1998
- 1998-05-25 ZA ZA984421A patent/ZA984421B/xx unknown
- 1998-05-27 CZ CZ0420099A patent/CZ298390B6/cs not_active IP Right Cessation
- 1998-05-27 KR KR1019997010988A patent/KR20010013014A/ko not_active Application Discontinuation
- 1998-05-27 HU HU0003249A patent/HUP0003249A3/hu unknown
- 1998-05-27 DE DE69832075T patent/DE69832075T2/de not_active Expired - Lifetime
- 1998-05-27 AR ARP980102464A patent/AR012872A1/es not_active Application Discontinuation
- 1998-05-27 AU AU76017/98A patent/AU740646B2/en not_active Ceased
- 1998-05-27 EP EP98923815A patent/EP1003506B1/en not_active Expired - Lifetime
- 1998-05-27 ES ES98923815T patent/ES2251083T3/es not_active Expired - Lifetime
- 1998-05-27 JP JP50086599A patent/JP2002500673A/ja active Pending
- 1998-05-27 PL PL336886A patent/PL191971B1/pl not_active IP Right Cessation
- 1998-05-27 WO PCT/US1998/010794 patent/WO1998053816A1/en active IP Right Grant
- 1998-05-27 BR BR9809611-7A patent/BR9809611A/pt not_active Application Discontinuation
- 1998-05-27 TW TW087108204A patent/TW579296B/zh not_active IP Right Cessation
- 1998-05-27 MX MXPA99010970A patent/MXPA99010970A/es not_active IP Right Cessation
- 1998-05-27 CA CA002288722A patent/CA2288722C/en not_active Expired - Fee Related
- 1998-05-27 AT AT98923815T patent/ATE307580T1/de not_active IP Right Cessation
- 1998-05-27 NZ NZ337888A patent/NZ337888A/en unknown
- 1998-05-27 CN CN98805305A patent/CN1257427A/zh active Pending
- 1998-05-27 IL IL13215498A patent/IL132154A/en not_active IP Right Cessation
- 1998-05-27 TR TR1999/02914T patent/TR199902914T2/xx unknown
- 1998-06-17 SA SA98190174A patent/SA98190174B1/ar unknown
-
1999
- 1999-11-26 NO NO19995797A patent/NO326141B1/no not_active IP Right Cessation
-
2001
- 2001-10-24 US US09/999,808 patent/US20020040045A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1003506A1 (en) | 2000-05-31 |
PL336886A1 (en) | 2000-07-17 |
ZA984421B (en) | 1998-11-27 |
AU7601798A (en) | 1998-12-30 |
AU740646B2 (en) | 2001-11-08 |
AR012872A1 (es) | 2000-11-22 |
DE69832075D1 (de) | 2005-12-01 |
KR20010013014A (ko) | 2001-02-26 |
ATE307580T1 (de) | 2005-11-15 |
CZ298390B6 (cs) | 2007-09-19 |
HUP0003249A3 (en) | 2002-02-28 |
NZ337888A (en) | 2001-04-27 |
CA2288722C (en) | 2007-04-24 |
CZ420099A3 (cs) | 2000-09-13 |
EP1003506A4 (en) | 2000-11-29 |
BR9809611A (pt) | 2000-07-04 |
PL191971B1 (pl) | 2006-07-31 |
EP1003506B1 (en) | 2005-10-26 |
TR199902914T2 (xx) | 2000-06-21 |
HUP0003249A2 (hu) | 2002-01-28 |
NO995797L (no) | 1999-11-26 |
IL132154A0 (en) | 2001-03-19 |
DE69832075T2 (de) | 2006-07-13 |
SA98190174B1 (ar) | 2006-05-13 |
ES2251083T3 (es) | 2006-04-16 |
JP2002500673A (ja) | 2002-01-08 |
US20020040045A1 (en) | 2002-04-04 |
WO1998053816A1 (en) | 1998-12-03 |
CA2288722A1 (en) | 1998-12-03 |
CN1257427A (zh) | 2000-06-21 |
NO995797D0 (no) | 1999-11-26 |
IL132154A (en) | 2002-12-01 |
TW579296B (en) | 2004-03-11 |
MXPA99010970A (es) | 2005-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR012614A1 (es) | Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento | |
HUP0003173A2 (hu) | A GLP-1 vagy analógjainak alkalmazása szívizominfarktus kezelésére használható gyógyszerkészítmények előállítására | |
NO883667D0 (no) | Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge. | |
CA2258095A1 (en) | Tetrahydrolipstatin containing compositions | |
FI944035A0 (fi) | Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen | |
HUP0101598A2 (hu) | Aszpartil proteáz inhibitorok prodrugjai és ezeket tartalmazó gyógyszerkészítmények | |
IS3644A7 (is) | Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur | |
IT1245761B (it) | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. | |
HUP0000299A1 (hu) | Késleltetett hatóanyag-leadású gyógyszerkészítmények | |
ATE81287T1 (de) | Am zielorgan wirkendes enterales abgabesystem. | |
CA2307018A1 (en) | Osmotic medicament releasing system | |
CA2326517A1 (en) | New galenic preparations of meloxicam for oral administration | |
RU93036959A (ru) | Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства | |
ATA285187A (de) | Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel | |
NO20006352L (no) | Anvendelse av diazepiner til fremstilling av medisiner for behandling av patologiske tilstander eller sykdommer som involverer en av veksthormon-frigjöringsinhiberingsfaktor- reseptorene | |
NZ229518A (en) | Pharmaceutical dosage form for the medication of fish: method of administration and (prophylactic) treatment | |
CA2283408A1 (en) | Swallow tablet comprising paracetamol | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
HUP9701777A2 (hu) | Raloxifene alkalmazása mellrák megelőzésére alkalmas gyógyszerkészítmények előállítására | |
CA2350659A1 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
EP0302714A3 (en) | Pharmaceutical composition for treatment of bone-wasting diseases | |
GR3017161T3 (en) | Multi-fractionable tablet structure. | |
DE69627160D1 (de) | Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma-butyrobetain für die behandlung von herz-gefäss-erkrankungen | |
WO2003099214A3 (en) | Biguanide formulations | |
NO326141B1 (no) | Fremgangsmate for behandling av isolert systolisk hypertensjon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |